QUOTE AND NEWS
Benzinga  Mar 14  Comment 
Analysts at Cowen & Company downgraded Plug Power (NASDAQ: PLUG) from “outperform” to “market perform.” The target price for Plug Power has been raised from $5.50 to $7.50. Plug Power's shares closed at $8.00 yesterday. Analysts at...
SeekingAlpha  Mar 13  Comment 
PhotoMedex, Inc. (PHMD) Q4 2013 Results Earnings Conference Call March 13, 2014 11:00 AM ET Executives Kim Golodetz - LHA Dr. Dolev Rafaeli - Chief Executive Officer Dennis McGrath - President and CFO Analysts Kay...
SeekingAlpha  Feb 17  Comment 
By Samir S. Patel: Dear Board, I am an LCA-Vision (LCAV) shareholder. After reviewing the details of the proposed transaction, I have concluded that the PhotoMedex (PHMD) offer materially undervalues the company. Thus, I am led to believe that...
SeekingAlpha  Feb 14  Comment 
PhotoMedex, Inc. (PHMD) LCA Vision Acquisition Call February 14, 2014 8:30 AM ET Executives Kim Golodetz – IR Dolev Rafaeli – CEO Dennis McGrath – President and CFO Mike Celebrezze – CEO Analysts William...
DailyFinance  Feb 14  Comment 
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of LCA-Vision, Inc. (“LCA-Vision” or the...
Reuters  Feb 13  Comment 
Skin health company PhotoMedex Inc said it would buy LCA-Vision Inc , which provides laser vision correction services under the Lasik Plus brand, for about $106 million.
DailyFinance  Feb 13  Comment 
PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) and LCA-Vision, Inc. (NasdaqGS: LCAV)today announced the signing of a definitive agreement pursuant to which PhotoMedex will acquire LCA-Vision for $5.37 per share in cash, or...
DailyFinance  Jan 6  Comment 
NEW YORK, NY -- (Marketwired) -- 01/06/14 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased PhotoMedex,...
Benzinga  Jan 2  Comment 
Oramed Pharmaceuticals (NASDAQ: ORMP) shares moved up 15.68% to $17.85. The volume of Oramed Pharmaceuticals shares traded was 971% higher than normal. Oramed received patent allowance in Israel, Australia for platform technology in oral delivery...
StreetInsider.com  Jan 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/PhotoMedex+%28PHMD%29+Sees+Higher+Q4+Sales/9016187.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki